• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by MEDIROM Healthcare Technologies Inc.

    12/10/24 7:38:12 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary
    Get the next $MRM alert in real time by email
    SC 13G 1 tm2429027d1_sc13g.htm SC 13G

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    (Rule 13d-102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO §240.13d-2

     

     

    MEDIROM Healthcare Technologies Inc.

    (Name of Issuer)

     

    American depositary shares, each representing one common share, no par value

    (Title of Class of Securities)

     

    58510H103

    (CUSIP Number)

     

    October 25, 2024

    (Date of Event which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨ Rule 13d-1 (b)

     

    x Rule 13d-1 (c)

     

    ¨ Rule 13d-1 (d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    (Continued on following page(s))

    Page 1 of 9 Pages

     

     

     

     

     

     

    CUSIP No. 58510H103 13G Page 2 of 9 Pages

     

      1    

      NAME OF REPORTING PERSON

     

    Triple One Investment Partnership

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

    (a)  ¨        (b)  ¨

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Japan

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        5    

      SOLE VOTING POWER

     

    380,019(1) 

      6    

      SHARED VOTING POWER

     

     0

      7    

      SOLE DISPOSITIVE POWER

     

    380,019(1)

      8    

      SHARED DISPOSITIVE POWER

     

      0

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    380,019(1)

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

    ¨

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    7.1%(2)

    12    

      TYPE OF REPORTING PERSON*

     

    PN

     

    (1) Represents (i) 66,540 Common Shares underlying American Depository Shares purchased in the open market and (ii) 313,479 Common Shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership. Following conversion, such Common Shares may be exchanged into American Depository Shares at any time by the holder pursuant to the Deposit Agreement among MEDIROM Healthcare Technologies Inc., The Bank Of New York Mellon, and holders of the American Depositary Receipts.
    (2)

    This percentage is based on 5,041,950 common shares outstanding and an aggregate of 380,019 common shares, comprised of (i) 66,540 common shares underlying American Depository Shares purchased in the open market and (ii) 313,479 common shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership, which are deemed to be outstanding and to be beneficially owned by the person holding the Convertible Bonds for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. The number of shares outstanding is based on the Issuer’s Registration Statement on Form F-1/A filed by the issuer with the Securities and Exchange Commission on December 4, 2024.

     

     

     

     

    CUSIP No. 58510H103 13G Page 3 of 9 Pages

     

      1    

      NAME OF REPORTING PERSON

     

    Kabushiki Kaisha CARPE DIEM

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

    (a)  ¨        (b)  ¨

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Japan

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        5    

      SOLE VOTING POWER

     

    380,019(1)

      6    

      SHARED VOTING POWER

     

    0

      7    

      SOLE DISPOSITIVE POWER

     

    380,019(1)

      8    

      SHARED DISPOSITIVE POWER

     

    0

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    7.1%(2)

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

    ¨

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    7.1%(2)

    12    

      TYPE OF REPORTING PERSON*

     

    CO

     

    (1) Represents (i) 66,540 Common Shares underlying American Depository Shares purchased in the open market and (ii) 313,479 Common Shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership. Following conversion, such Common Shares may be exchanged into American Depository Shares at any time by the holder pursuant to the Deposit Agreement among MEDIROM Healthcare Technologies Inc., The Bank Of New York Mellon, and holders of the American Depositary Receipts. Kabushiki Kaisha CARPE DIEM is the Representative Partner of Triple One Investment Partnership. Kabushiki Kaisha CARPE DIEM disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.
    (2)

    This percentage is based on 5,041,950 common shares outstanding and an aggregate of 380,019 common shares, comprised of (i) 66,540 common shares underlying American Depository Shares purchased in the open market and (ii) 313,479 common shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership, which are deemed to be outstanding and to be beneficially owned by the person holding the Convertible Bonds for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. The number of shares outstanding is based on the Issuer’s Registration Statement on Form F-1/A filed by the issuer with the Securities and Exchange Commission on December 4, 2024.

     

     

     

     

    CUSIP No. 58510H103 13G Page 4 of 9 Pages

     

      1    

      NAME OF REPORTING PERSON

     

    Takao Shimura

      2    

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     

    (a)  ☐        (b)  ☐

      3    

      SEC USE ONLY

     

      4    

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Japan

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

        5    

      SOLE VOTING POWER

     

    380,019(1)

      6    

      SHARED VOTING POWER

     

    0

      7    

      SOLE DISPOSITIVE POWER

     

    380,019(1)

      8    

      SHARED DISPOSITIVE POWER

     

    0

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    7.1%(2)

    10    

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

    ☐

    11    

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    7.1%(2)

    12    

      TYPE OF REPORTING PERSON*

     

    IN

     

    (1) Represents (i) 66,540 Common Shares underlying American Depository Shares purchased in the open market and (ii) 313,479 Common Shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership. Following conversion, such Common Shares may be exchanged into American Depository Shares at any time by the holder pursuant to the Deposit Agreement among MEDIROM Healthcare Technologies Inc., The Bank Of New York Mellon, and holders of the American Depositary Receipts. Kabushiki Kaisha CARPE DIEM is the Representative Partner of Triple One Investment Partnership.  Takao Shimura is the Representative Director of Kabushiki Kaisha CARPE DIEM, and Kabushiki Kaisha CARPE DIEM is majority owned and controlled by Takao Shimura.  Mr. Shimura disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
    (2)

    This percentage is based on 5,041,950 common shares outstanding and an aggregate of 380,019 common shares, comprised of (i) 66,540 common shares underlying American Depository Shares purchased in the open market and (ii) 313,479 common shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership, which are deemed to be outstanding and to be beneficially owned by the person holding the Convertible Bonds for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. The number of shares outstanding is based on the Issuer’s Registration Statement on Form F-1/A filed by the issuer with the Securities and Exchange Commission on December 4, 2024.

     

     

     

     

    CUSIP No. 58510H103 13G Page 5 of 9 Pages

     

    Explanatory Note

     

    Item 1.

     

      (a) Name of Issuer: MEDIROM Healthcare Technologies Inc.

     

      (b) Address of Issuer’s Principal Executive Offices:

     

    2-3-1, Daiba, Minato-ku, Tokyo, Japan

     

    Item 2.

     

      (a) Name of Person Filing:

     

    This statement is filed by:

     

    (i) Triple One Investment Partnership

    (ii) Kabushiki Kaisha CARPE DIEM

    (iii) Takao Shimura

     

    (b) Address of Principal Business Office or if none, Residence:

     

    Toranomon 33 Mori Building 3-8-21

    Toranomon, Minato-ku, Tokyo

     

      (c) Citizenship:

     

    Triple One Investment Partnership – Japan

     

    Kabushiki Kaisha CARPE DIEM – Japan

     

    Takao Shimura – Japan

     

      (d) Title of Class of Securities: American depositary shares, each representing one common share, no par value.

     

      (e) CUSIP Number: 58510H103

     

    Item 3. Not Applicable

     

    Item 4. Ownership.

     

      (a) Amount Beneficially Owned:

     

    Triple One Investment Partnership - 380,019. Represents (i) 66,540 Common Shares underlying American Depository Shares purchased in the open market and (ii) 313,479 Common Shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership. Following conversion, such Common Shares may be exchanged into American Depository Shares at any time by the holder pursuant to the Deposit Agreement among MEDIROM Healthcare Technologies Inc., The Bank Of New York Mellon, and holders of the American Depositary Receipts (the “Deposit Agreement”).

     

    Kabushiki Kaisha CARPE DIEM - 380,019. Represents (i) 66,540 Common Shares underlying American Depository Shares purchased in the open market and (ii) 313,479 Common Shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership. Following conversion, such Common Shares may be exchanged into American Depository Shares at any time by the holder pursuant to the Deposit Agreement. Kabushiki Kaisha CARPE DIEM is the Representative Partner of Triple One Investment Partnership. Kabushiki Kaisha CARPE DIEM disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.

     

    Takao Shimura - 380,019. Represents (i) 66,540 Common Shares underlying American Depository Shares purchased in the open market and (ii) 313,479 Common Shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership. Following conversion, such Common Shares may be exchanged into American Depository Shares at any time by the holder pursuant to the Deposit Agreement. Kabushiki Kaisha CARPE DIEM is the Representative Partner of Triple One Investment Partnership. Takao Shimura is the Representative Director of Kabushiki Kaisha CARPE DIEM, and Kabushiki Kaisha CARPE DIEM is majority owned and controlled by Takao Shimura. Mr. Shimura disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.

     

     

     

     

    CUSIP No. 58510H103 13G Page 6 of 9 Pages

     

      (b) Percent of Class:

     

    Triple One Investment Partnership – 7.1% This percentage is based on 5,041,950 common shares outstanding and an aggregate of 380,019 common shares, comprised of (i) 66,540 common shares underlying American Depository Shares purchased in the open market and (ii) 313,479 common shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership, which are deemed to be outstanding and to be beneficially owned by the person holding the Convertible Bonds for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. The number of shares outstanding is based on the Issuer’s Registration Statement on Form F-1/A filed by the issuer with the Securities and Exchange Commission on December 4, 2024.

     

    Kabushiki Kaisha CARPE DIEM – 7.1%. This percentage is based on 5,041,950 common shares outstanding and an aggregate of 380,019 common shares, comprised of (i) 66,540 common shares underlying American Depository Shares purchased in the open market and (ii) 313,479 common shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership, which are deemed to be outstanding and to be beneficially owned by the person holding the Convertible Bonds for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. The number of shares outstanding is based on the Issuer’s Registration Statement on Form F-1/A filed by the issuer with the Securities and Exchange Commission on December 4, 2024.

     

    Takao Shimura - 7.1%. This percentage is based on 5,041,950 common shares outstanding and an aggregate of 380,019 common shares, comprised of (i) 66,540 common shares underlying American Depository Shares purchased in the open market and (ii) 313,479 common shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership, which are deemed to be outstanding and to be beneficially owned by the person holding the Convertible Bonds for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. The number of shares outstanding is based on the Issuer’s Registration Statement on Form F-1/A filed by the issuer with the Securities and Exchange Commission on December 4, 2024.

     

      (c) Number of shares as to which such person has:

     

      (i) sole power to vote or to direct the vote:

     

    Triple One Investment Partnership - 380,019. Represents (i) 66,540 Common Shares underlying American Depository Shares purchased in the open market and (ii) 313,479 Common Shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership. Following conversion, such Common Shares may be exchanged into American Depository Shares at any time by the holder pursuant to the Deposit Agreement.

     

    Kabushiki Kaisha CARPE DIEM -380,019. Represents (i) 66,540 Common Shares underlying American Depository Shares purchased in the open market and (ii) 313,479 Common Shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership. Following conversion, such Common Shares may be exchanged into American Depository Shares at any time by the holder pursuant to the Deposit Agreement. Kabushiki Kaisha CARPE DIEM is the Representative Partner of Triple One Investment Partnership. Kabushiki Kaisha CARPE DIEM disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.

     

    Takao Shimura - 380,019. Represents (i) 66,540 Common Shares underlying American Depository Shares purchased in the open market and (ii) 313,479 Common Shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership. Following conversion, such Common Shares may be exchanged into American Depository Shares at any time by the holder pursuant to the Deposit Agreement. Kabushiki Kaisha CARPE DIEM is the Representative Partner of Triple One Investment Partnership. Takao Shimura is the Representative Director of Kabushiki Kaisha CARPE DIEM, and Kabushiki Kaisha CARPE DIEM is majority owned and controlled by Takao Shimura. Mr. Shimura disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.

     

      (ii) shared power to vote or to direct the vote:

     

    Triple One Investment Partnership - 0.

     

    Kabushiki Kaisha CARPE DIEM – 0

     

    Takao Shimura – 0

     

      (iii) sole power to dispose or to direct the disposition of:

     

    Triple One Investment Partnership - 380,019. Represents (i) 66,540 Common Shares underlying American Depository Shares purchased in the open market and (ii) 313,479 Common Shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership. Following conversion, such Common Shares may be exchanged into American Depository Shares at any time by the holder pursuant to the Deposit Agreement.

     

    Kabushiki Kaisha CARPE DIEM - 380,019. Represents (i) 66,540 Common Shares underlying American Depository Shares purchased in the open market and (ii) 313,479 Common Shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership. Following conversion, such Common Shares may be exchanged into American Depository Shares at any time by the holder pursuant to the Deposit Agreement. Kabushiki Kaisha CARPE DIEM is the Representative Partner of Triple One Investment Partnership. Kabushiki Kaisha CARPE DIEM disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.

     

    Takao Shimura - 380,019. Represents (i) 66,540 Common Shares underlying American Depository Shares purchased in the open market and (ii) 313,479 Common Shares issuable upon conversion of the Convertible Bonds held by Triple One Investment Partnership. Following conversion, such Common Shares may be exchanged into American Depository Shares at any time by the holder pursuant to the Deposit Agreement. Kabushiki Kaisha CARPE DIEM is the Representative Partner of Triple One Investment Partnership. Takao Shimura is the Representative Director of Kabushiki Kaisha CARPE DIEM, and Kabushiki Kaisha CARPE DIEM is majority owned and controlled by Takao Shimura. Mr. Shimura disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.

     

      (iv) shared power to dispose or to direct the disposition of:

     

    Triple One Investment Partnership - 0.

     

    Kabushiki Kaisha CARPE DIEM – 0

     

    Takao Shimura – 0

     

     

     

     

    CUSIP No. 58510H103 13G Page 7 of 9 Pages

     

    Item 5. Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [  ].

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person: Not Applicable

     

    Item 7. Identification and Classification of Subsidiary Which Acquired the Securities: Not Applicable

     

    Item 8. Identification and Classification of Members of the Group: Not Applicable.

     

    Item 9. Notice of Dissolution of Group: Not Applicable

     

    Item 10. Certifications: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

    CUSIP No. 58510H103 13G Page 8 of 9 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    December 10, 2024

     

      TRIPLE ONE INVESTMENT PARTNERSHIP
       
      By: Kabushiki Kaisha CARPE DIEM, its Representative Partner.
         
      By:

    /s/ Takao Shimura

      Name: Takao Shimura
      Title: Authorized Signatory
         
      Kabushiki Kaisha CARPE DIEM
         
      By:

    /s/ Takao Shimura

      Name: Takao Shimura
      Title: Representative Director
         
      By: /s/ Takao Shimura
      Name: Takao Shimura

     

    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, Provided, however, That a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

     

     

     

     

    CUSIP No. 58510H103 13G Page 9 of 9 Pages

     

    EXHIBIT 1

     

    JOINT FILING AGREEMENT

     

    In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the common shares, no par value, of MEDIROM Healthcare Technologies Inc., a joint stock corporation with limited liability organized under the laws of Japan, and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filings.

     

    The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13G and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate.

     

    This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

     

    IN WITNESS WHEREOF, the undersigned have executed this agreement as of December 10, 2024.

     

      TRIPLE ONE INVESTMENT PARTNERSHIP
       
      By: Kabushiki Kaisha CARPE DIEM, its Representative Partner.
         
      By:

    /s/ Takao Shimura

      Name: Takao Shimura
      Title: Authorized Signatory
         
      KABUSHIKI KAISHA CARPE DIEM
         
      By:

    /s/ Takao Shimura

      Name: Takao Shimura
      Title: Representative Director
         
      By: /s/ Takao Shimura
      Name: Takao Shimura

     

     

     

    Get the next $MRM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MRM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MRM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • MEDIROM Healthcare Technologies Inc. Announces 22% Rise in Revenue and 20% Improvement in Earnings for 2024; Webcast to Discuss Financial Results to be held on May 21st, 2025 at 8:30 AM ET

      TOKYO, May 20, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the "Company" or "MEDIROM"), today announced that for the year ended December 31, 2024, the Company had total revenue of $52,736,000, a 22% increase over total revenue of $43,388,000 for the year ended December 31, 2023. (The Company reports its financial results in Japanese yen and figures presented in this press release in US dollars have been translated for convenience at the exchange rate of ¥ 157.37 = US$1.00. See "Convenience Translations to US Dollars" below for more information.) Net income for 2024 was $878,000, or $0.17 per basic share,

      5/20/25 8:56:16 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results

      TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the "Company" or "MEDIROM") today announced that it will host a webcast to review the Company's financial results for the fiscal year ended December 31, 2024, on Wednesday, May 21, 2025 at 8:30 am Eastern Time. The Company will issue a press release discussing those results after the market close on Tuesday, May 20th, 2025. In addition, on April 29, 2025, the Company filed its most recent annual report on Form 20-F, which annual report covers the Company's financial results for the 2024 fiscal year and is available on the Securities and Exchange Comm

      5/19/25 8:44:53 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • MEDIROM Healthcare Technologies Inc. Announces New JPY350 Million (Approximately $2.4 Million*) Unsecured Loan Financing

      TOKYO, March 17, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the "Company" or "MEDIROM"), today announced that it has obtained a new unsecured short-term bank loan in the amount of JPY350 million (approximately $2.4 million*). The Company has used JPY200 million of the loan funds for repayment of indebtedness of MEDIROM Mother Labs Inc., a subsidiary of the Company which is also a guarantor of the new loan, and the Company intends to use the remainder of the loan funds for general working capital, including Mother Bracelet development. The loan bears interest at a rate of 1.875% per year. "This new loan fina

      3/17/25 5:30:00 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary

    $MRM
    SEC Filings

    See more
    • SEC Form 6-K filed by MEDIROM Healthcare Technologies Inc.

      6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

      5/20/25 8:00:20 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form 6-K filed by MEDIROM Healthcare Technologies Inc.

      6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

      5/20/25 6:10:32 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form 20-F filed by MEDIROM Healthcare Technologies Inc.

      20-F - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

      4/29/25 4:15:44 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary

    $MRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by MEDIROM Healthcare Technologies Inc.

      SC 13G - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

      12/10/24 7:38:12 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form SC 13D filed by MEDIROM Healthcare Technologies Inc.

      SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

      1/25/23 4:16:06 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form SC 13D filed by MEDIROM Healthcare Technologies Inc.

      SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

      1/6/23 6:12:19 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary

    $MRM
    Leadership Updates

    Live Leadership Updates

    See more
    • "NASDAQ JAPAN IR EVENT" to Be Held at Nasdaq MarketSite on June 20, 2024

      NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan ("MEDIROM", the "Company"), today announced it will participate in a "NASDAQ JAPAN IR EVENT" to be held at Nasdaq MarketSite in Times Square on June 20, 2024. Five companies are currently expected to join this event (including one private company), and we will share information about the attractive nature of the Japanese market with a global audience. PurposeIn December 2020, the Company became the first Japanese company in 21 years to list on Nasdaq. Today, the number of Japanese companies listed on Nasdaq has increased to eight. While more and mor

      5/20/24 3:00:00 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary

    $MRM
    Financials

    Live finance-specific insights

    See more
    • MEDIROM Rehab Solutions Inc. Acquires Rehabilitation Centers from Y's, Inc.

      TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company") is pleased to announce that it is capitalizing on its extensive experience operating wellness clinics and healthcare technology to expand into the rehabilitation industry. In doing so, MEDIROM established a wholly-owned subsidiary, MEDIROM Rehab Solutions Inc., which acquired all of the rehabilitation centers of Y's, Inc. Prior to the acquisition by MEDIROM Rehab Solutions Inc., Y's, Inc. owned and operated ten cerebral infarction rehabilitation centers in Tokyo and other major cities across Japan. Cerebral infarction rehabilitation is a comprehensive program designed to

      10/7/24 4:00:00 PM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • MEDIROM Healthcare Technologies Inc. Announces Financial Results for Fiscal Year 2023

      TOKYO, June 25, 2024 (GLOBE NEWSWIRE) --  MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company"), a holistic healthcare company based in Japan, announced it filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC"), including consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP"), on June 18, 2024. Kouji Eguchi, Chief Executive Officer of the Company, stated, "I am very pleased to announce that during a period of significant investment and development in our healthcare technology systems and products in FY 2023 and FY 2022, as wel

      6/25/24 9:37:44 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary
    • MEDIROM Healthcare Technologies Inc. Announces Preliminary 2021 Financial Results

      NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the "Company"), today announced its preliminary unaudited financial results for the fiscal year ended December 31, 2021, prepared in accordance with U.S. GAAP. Due to additional time required to complete its year-end reporting process, the Company determined that it was unable to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2021, within the prescribed time period without unreasonable effort and expense. The Company filed a Notification of Late Filing on Form 12b-25 with the U.S. Securities and Exchange Commission o

      5/13/22 7:53:59 AM ET
      $MRM
      Other Consumer Services
      Consumer Discretionary